<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,

Program

Organization Authors

Co-Authors

Etzion, Ohad

Hamid, Saeed Sadiq

Asselah, Tarik

Gherlan, George Sebastian

Turcanu, Adela

Petrivna, Tsarynna

Weissfeld, Lisa

Choong, Ingrid

Hislop, Colin

Apelian, David

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Source

Publisher

Elsevier

Citation

item.page.haspartof

Source

Journal of Hepatology

item.page.ispartofseries

item.page.edition

DOI

10.1016/S0168-8278(23)00451-8

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators